Enrollment on track for both pivotal trials of zanidatamab in 1L gastroesophageal adenocarcinoma (GEA) and 2L biliary tract cancer (BTC). Announced submission of abstracts for upcoming clinical data for the 2022 American Society for Clinical Oncology
Total revenue of $375 million, up from $233 million in 2020, and liquidity of over $720 million Total cumulative program starts of 78, with 26 new starts in the year EPS of $0.56 (basic) and $0.48 (diluted) compared to $0.53 (basic) and $0.45 (dilut
ANN ARBOR, Mich.--(BUSINESS WIRE)--The Coretec Group, Inc., (OTCQB: CRTG), a developer of engineered silicon and 3D volumetric displays, has opened a new wet laboratory and hired a research scientist. The new lab is located in the same building as the co
A vaccine manufactured in plants and developed in Canada QUEBEC CITY & LONDON--(BUSINESS WIRE)--Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announced that Health Canada has granted approval for COVI
PASADENA, Calif.--(BUSINESS WIRE)--#NAE--Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering services, congratulates Dr. Leslie L. Shoemaker, Tetra Tech President and Chief Sustainability Officer, on her election to
TORONTO--(BUSINESS WIRE)--Juno Pharmaceuticals Corp (“Juno”), a Canadian specialty generics pharmaceuticals company, announced that it has received a strategic growth investment from Signet Healthcare Partners (“Signet”), a New York-based healthca
TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-
TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: CRSWF) (FSE: 3XI), a leading biotech company focused on innovation and research on endogenous tryptamines (biomolecules acting as psychoneuroplastogens
Mednow provides annual growth forecasts for the calendar year 2022 and 2023; In the 2022 calendar year, revenue is forecasted to range between C$42.5M and C$47.5M; approximately C$42M will come from its pharmacy services, while approximately C$3M will
BAT’s Simon Ashton Appointed to the Board of Directors MONCTON, New Brunswick--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual meeting of
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.